Viewing StudyNCT06437639

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-06-16 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06437639
Status: COMPLETED
Last Update Posted: 2024-05-31
First Post: 2024-05-24
Brief Title: MEXIDOL Sequential Therapy of Patients With Primary Open-angle Glaucoma POAG
Sponsor: Pharmasoft
Organization: Pharmasoft
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Primary Open-Angle Glaucoma POAG
Keywords:
Name View
Ethylmethylhydroxypyridine Succinate View
Glaucoma View
Primary Open-Angle Glaucoma POAG View
Glaucomatous Optic Neuropathy GON View
Mitochondrial Dysfunction View
Neuroprotection View
Mexidol View